October 2019 - GU CONNECT

GU CONNECT Update from ESMO 2019

by healios | Oct 9, 2019 | gu updates

GU CONNECT Update from ESMO 2019 GU CONNECT has summarised highlights of the recent ESMO 2019 meeting for you GU Cancer by Prof. Neeraj Agarwal, University of Utah School of Medicine, Utah, USA 00:00:06 Chapter #1 - Introduction00:00:33 Chapter #2 - PROfound00:04:28...

New therapies for metastatic hormone sensitive prostate cancer

by healios | Oct 9, 2019 | your clinical answers

New therapies for metastatic hormone sensitive prostate cancer As an experienced urologist and member of GU CONNECT, Prof. David Pfister provides his perspective on new therapies for mHSPC. Download the slides For additional discussion on this important topic then...

Treating Oligometastatic Prostate Cancer

by healios | Oct 9, 2019 | your clinical answers

Treating Oligometastatic Prostate Cancer Assoc. Prof. Tanya B. Dorff looks into the use of imaging along with the treatment of oligometastatic prostate cancer Download the slides Treating oligometastatic prostate cancer Assoc. Prof. Tanya B Dorff examines the...

Newly defined criteria for “platinum-ineligible” patients with metastatic urothelial cancer (mUC)

by healios | Oct 9, 2019 | your clinical answers

Newly defined criteria for “platinum-ineligible” patients with metastatic urothelial cancer (mUC) Asst. Prof. Shilpa Gupta discusses the newly defined criteria for “platinum-ineligibility” in patients with metastatic urothelial cancer on behalf of the...

GU CONNECT Update from ESMO 2019

New therapies for metastatic hormone sensitive prostate cancer

Treating Oligometastatic Prostate Cancer

Newly defined criteria for “platinum-ineligible” patients with metastatic urothelial cancer (mUC)

Recent Posts

Recent Comments

Archives

Categories

Meta

Are you a healthcare professional?

Thanks for visiting this website